Evidence map›Paper›PMID 42072350›Full record

ReviewBiomedicines2026

A Holistic Approach to Unravel Keloid Pathogenesis and Optimize Therapeutic Outcomes.

Zhendong Cao, Wei Liu

Abstract readReview
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhendong CaoDepartment of Traditional Chinese Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
Wei LiuDepartment of Plastic and Reconstructive Surgery, Shanghai Tissue Engineering Key Laboratory, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.

Funding

Major Basic Research Projects of the Natural Science Foundation of Shandong Province ZR2024ZD24National Natural Science Foundation of China 81671921
6 · The paper itself

Abstract

Although tremendous progress has been made over the past decades in elucidating the mechanisms of keloid formation and developing therapeutic interventions, keloid remains challenging to cure and prone to recurrence. Historically, keloid has been regarded as a benign skin tumor, with mechanistic investigations and therapeutic efforts focused primarily on keloid tissue and cells themselves. In contrast, Traditional Chinese Medicine (TCM) posits that skin diseases manifest from internal bodily dysfunction or dysregulation. Inspired by the holistic principles of TCM, together with the literature reports and clinical evidence of keloid constitution (a systemic condition characterized by an individual's predisposition to keloid formation), we propose that keloid is likely a pseudo-skin tumor profoundly influenced by its pathological microenvironment. Accordingly, we propose keloid as a persistent inflammation-driven proliferative skin disorder, and elimination of the inflammatory microenvironment may be essential for curing keloid and preventing relapse. Based on this concept, we developed a holistic therapeutic approach that combines systemic treatment targeting keloid constitution with local therapies, including surgery, chemo/radiotherapy, and compression therapy, for the keloid lesion itself. The systemic component encompasses lifestyle and dietary modifications, stress management, physical exercise, as well as the oral administration of TCM herbal medicines and small chemical compounds to suppress systemic inflammatory and fibrotic status, thereby improving keloid constitution. This article introduces this novel holistic approach along with supportive case studies.

Indexed as

combined systemic and local therapiesholistic approachkeloidpro-inflammatory/fibrotic constitutionTraditional Chinese Medicine (TCM)

Identifiers

PMID42072350
PMCPMC13113866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.